Published in Arthritis Rheum on June 01, 1999
Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet (2005) 6.61
Genetics of rheumatoid arthritis: confronting complexity. Arthritis Res (1999) 1.63
Predictive value of interleukin 1 gene polymorphisms for surgery. Ann Rheum Dis (2000) 1.38
Biological role of interleukin 1 receptor antagonist isoforms. Ann Rheum Dis (2000) 1.30
Association of interleukin-6 and interleukin-10 genotypes with radiographic damage in rheumatoid arthritis is dependent on autoantibody status. Arthritis Rheum (2007) 1.07
Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. World J Gastroenterol (2011) 1.01
Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis. Arthritis Res Ther (2004) 0.97
Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies. Clin Exp Immunol (2000) 0.96
Genes and environment in arthritis: can RA be prevented? Arthritis Res (2002) 0.96
Association of -31T>C and -511 C>T polymorphisms in the interleukin 1 beta (IL1B) promoter in Korean keratoconus patients. Mol Vis (2008) 0.95
Identification of arthritis-related gene clusters by microarray analysis of two independent mouse models for rheumatoid arthritis. Arthritis Res Ther (2006) 0.95
The -590 IL-4 promoter polymorphism in patients with rheumatoid arthritis. Rheumatol Int (2005) 0.89
Association of polymorphism in the transforming growth factor {beta}1 gene with disease outcome and mortality in rheumatoid arthritis. Ann Rheum Dis (2005) 0.86
The effects of gene polymorphisms in interleukin-4 and interleukin-6 on the susceptibility of rheumatoid arthritis in a Chinese population. Biomed Res Int (2014) 0.86
Polymorphisms for interleukin-1 beta (IL-1 beta)-511 promoter, IL-1 beta exon 5, and IL-1 receptor antagonist: nonassociation with endometriosis. J Assist Reprod Genet (2001) 0.83
Tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients. Clin Rheumatol (2008) 0.82
Gene polymorphisms of TNF-alpha(-308), IL-10(-1082), IL-6(-174), and IL-1Ra(VNTR) related to susceptibility and severity of rheumatic heart disease. Pediatr Cardiol (2007) 0.81
Interleukin-10 promoter polymorphism in patients with rheumatoid arthritis. Clin Rheumatol (2005) 0.81
The effect of IL-4 gene polymorphisms on cytokine production in patients with chronic periodontitis and in healthy controls. Mediators Inflamm (2014) 0.80
Genetic epidemiology. Approaches to the genetic analysis of rheumatoid arthritis. Arthritis Res (2001) 0.80
IL4 in the 5q31 context: association studies of type 1 diabetes and rheumatoid arthritis in the Spanish population. Immunogenetics (2007) 0.80
Gene polymorphisms and pharmacogenetics in rheumatoid arthritis. Curr Genomics (2008) 0.80
A broad analysis of IL1 polymorphism and rheumatoid arthritis. Arthritis Rheum (2008) 0.79
Association between polymorphism of interleukin-1 beta and interleukin-1 receptor antagonist gene and asthma risk: a meta-analysis. ScientificWorldJournal (2015) 0.79
Immunological parameters and gene polymorphisms (C-590T IL4, C-597A IL10) in severe bronchial asthma in children from the Krasnoyarsk region, West Siberia. Int J Circumpolar Health (2013) 0.77
A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis. Arthritis Res Ther (2015) 0.77
IL1 gene polymorphisms in enthesitis related arthritis category of juvenile idiopathic arthritis (ERA-JIA). Clin Rheumatol (2011) 0.77
HLA-DRB1 gene transcripts in rheumatoid arthritis. Clin Exp Immunol (2001) 0.77
Genetic polymorphisms and asthma: findings from a case-control study in the Madeira island population. Biol Res (2014) 0.76
Interleukin-1 Receptor Antagonist and Interleukin-4 Genes Variable Number Tandem Repeats Are Associated with Adiposity in Malaysian Subjects. J Obes (2017) 0.75
Study of interleukin-1 receptor antagonist (IL-1Ra) gene polymorphism in healthy individuals from Northern India. Indian J Clin Biochem (2004) 0.75
Promoter polymorphism (-590, T/C) of interleukin 4 (IL4) gene is associated with rheumatoid arthritis: An updated meta-analysis. Saudi J Biol Sci (2016) 0.75
Interleukin-1β (IL-1β) & IL-4 gene polymorphisms in patients with systemic lupus erythematosus (SLE) & their association with susceptibility to SLE. Indian J Med Res (2016) 0.75
Interleukin-1 gene cluster variants in hemodialysis patients with end stage renal disease: An association and meta-analysis. Indian J Nephrol (2015) 0.75
High interleukin-4 expression and interleukin-4 gene polymorphisms are associated with susceptibility to human paracoccidioidomycosis. Mem Inst Oswaldo Cruz (2015) 0.75
The Clinical Significance of Interleukin-1 Receptor Antagonist +2018 Polymorphism in Rheumatoid Arthritis. PLoS One (2016) 0.75
Meta-analysis of SLC22A4 and RUNX1 polymorphisms : Associations with rheumatoid arthritis susceptibility. Z Rheumatol (2015) 0.75
No relationship of -627 interleukin-10 promoter polymorphism in Chinese patients with rheumatoid arthritis. Rheumatol Int (2004) 0.75
Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging (2009) 5.98
Description of 1,108 older patients referred by their physician to the "Geriatric Frailty Clinic (G.F.C) for Assessment of Frailty and Prevention of Disability" at the gerontopole. J Nutr Health Aging (2014) 3.37
The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition (1999) 3.28
Incidence and predictive factors for infectious disease after rituximab therapy in kidney-transplant patients. Am J Transplant (2009) 3.19
Cognitive frailty: rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group. J Nutr Health Aging (2013) 2.44
Stenosis of the lumbar spinal canal in vertebral ankylosing hyperostosis. Spine (Phila Pa 1976) (1992) 2.07
Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol (1993) 1.95
EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis (2009) 1.95
The primary care physician and Alzheimer's disease: an international position paper. J Nutr Health Aging (2010) 1.68
Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis. Clin Exp Rheumatol (2004) 1.66
Protein-energy oral supplementation in malnourished nursing-home residents. A controlled trial. Age Ageing (2000) 1.63
Letter: Factor-VIII complex and endothelial damage. Lancet (1975) 1.61
Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis. J Rheumatol (1998) 1.59
[Late myopathies located at the spinal muscles: a cause of acquired lumbar kyphosis in adults]. Rev Rhum Mal Osteoartic (1991) 1.59
Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. J Rheumatol (1996) 1.56
Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology (1997) 1.55
Relation between HLA DRB1 alleles and corticosteroid resistance in giant cell arteritis. Ann Rheum Dis (1998) 1.51
Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) as the first manifestation of periarteritis nodosa. Report of a case. Rev Rhum Engl Ed (1995) 1.44
IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging (2007) 1.44
[Should long-term corticosteroid treatment be given in rheumatoid arthritis?]. Rev Rhum Ed Fr (1993) 1.39
Neurosensory adverse effects after phenylbutazone and misoprostol combined treatment. Lancet (1989) 1.39
New-onset acute heart failure and ventricular tachycardia after therapy with a tumor necrosis factor antagonist. Clin Exp Rheumatol (2005) 1.38
IANA (International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer's disease. J Nutr Health Aging (2007) 1.28
Isolation from Candida albicans of a functional homolog of the Saccharomyces cerevisiae KRE1 gene, which is involved in cell wall beta-glucan synthesis. J Bacteriol (1991) 1.24
Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404. Eur J Pharmacol (2000) 1.21
Duodenal villous atrophy: a cause of chronic diarrhea after solid-organ transplantation. Am J Transplant (2011) 1.20
Morphological analyses of paraspinal muscles: comparison of progressive lumbar kyphosis (camptocormia) and narrowing of lumbar canal by disc protrusions. Neuromuscul Disord (1994) 1.20
Kinetics of intracytoplasmic Th1 and Th2 cytokine production assessed by flow cytometry following in vitro activation of peripheral blood mononuclear cells. Cytometry (1999) 1.18
First line treatment of knee osteoarthritis in outpatients in France: adherence to the EULAR 2000 recommendations and factors influencing adherence. Ann Rheum Dis (2005) 1.16
Developmental regulation of the synthesis of proteins encoded by stored mRNA in radish embryos. Plant Physiol (1984) 1.13
Health status and health services utilization of Canada's immigrant and non-immigrant populations. Can Public Policy (2000) 1.09
Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab. Ann Rheum Dis (2012) 1.09
Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance. Tissue Antigens (2000) 1.08
[Study of CD45 isoforms on T CD8 lymphocytes, in the peripheral blood and the graft in patients after kidney transplantation]. Presse Med (1992) 1.08
One-leg standing balance and functional status in a population of 512 community-living elderly persons. Aging (Milano) (1997) 1.07
Weight loss in Alzheimer disease. Am J Clin Nutr (2000) 1.07
[Primary camptocormia is a para-vertebral myopathy]. Rev Rhum Ed Fr (1994) 1.06
Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort. Ann Rheum Dis (2005) 1.05
HLA-A, B, C, DR antigens, Bf, C4 and glyoxalase I (GLO) polymorphisms in French Basques with insulin-dependent diabetes mellitus (IDDM). Tissue Antigens (1982) 1.04
Oral Rh treatment for severely immunised mothers. Lancet (1979) 1.01
Nutrition assessment in the elderly. Curr Opin Clin Nutr Metab Care (2001) 1.00
Mustard allergy in children. Allergy (2000) 0.97
Measurement of the radiological hip joint space width. An evaluation of various methods of measurement. Osteoarthritis Cartilage (2001) 0.96
Effect of oral monthly ibandronate on bone microarchitecture in women with osteopenia-a randomized placebo-controlled trial. Osteoporos Int (2012) 0.94
A nutritional education program could prevent weight loss and slow cognitive decline in Alzheimer's disease. J Nutr Health Aging (2001) 0.94
HLA class I antibodies provoke graft arteriosclerosis in human arteries transplanted into SCID/beige mice. Am J Transplant (2009) 0.93
Bone mineral decrease in the leg with unilateral chronic occlusive arterial disease. Clin Exp Rheumatol (2003) 0.93
Relevant change in radiological progression in patients with hip osteoarthritis. I. Determination using predictive validity for total hip arthroplasty. Rheumatology (Oxford) (2002) 0.93
Immunoblotting detection of so-called 'antikeratin antibodies': a new assay for the diagnosis of rheumatoid arthritis. Ann Rheum Dis (1994) 0.92
Human collagen II peptide 256-271 preferentially binds to HLA-DR molecules associated with susceptibility to rheumatoid arthritis. Immunogenetics (1999) 0.92
How should we deal with missing data in clinical trials involving Alzheimer's disease patients? Curr Alzheimer Res (2011) 0.92
Detection of J chain in lymphomas and related disorders. Clin Exp Immunol (1981) 0.91
Sonography of the hypertrophied column of Bertin. AJR Am J Roentgenol (1986) 0.91
Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives. J Nutr Health Aging (2008) 0.91
Association of common genetic variants with colorectal cancer risk in a Romanian sample. Chirurgia (Bucur) (2011) 0.91
[Iconography of Buschke Ollendorff syndrome: x ray computed tomography and nuclear magnetic resonance of osteopoikilosis]. Ann Dermatol Venereol (1989) 0.90
[Osteonecrosis: natural course and conservative therapy]. Orthopade (2000) 0.90
Intensive combined therapy for previously untreated aggressive myeloma. Blood (1992) 0.90
New insights into the genetics of immune responses in rheumatoid arthritis. Tissue Antigens (2012) 0.90
The susceptibility to insulin-dependent diabetes mellitus is associated with C4 allotypes independently of the association with HLA-DQ alleles in HLA-DR3,4 heterozygotes. Immunogenetics (1988) 0.90
[Coxarthroses due to ischemia. Ischemic coxarthropathy]. Rev Rhum Mal Osteoartic (1978) 0.90
Medical treatment of reflex sympathetic dystrophy. Hand Clin (1997) 0.90
HLA class II allele and haplotype frequencies in Ethiopian Amhara and Oromo populations. Tissue Antigens (1998) 0.90
Whole body and regional bone mineral density in ankylosing spondylitis. J Rheumatol (2001) 0.90
[The hip in vertebral hyperostosis]. Rev Rhum Mal Osteoartic (1978) 0.89
Radiographic features predictive of radiographic progression of hip osteoarthritis. Rev Rhum Engl Ed (1997) 0.89
Substance P enhances cytokine-induced vascular cell adhesion molecule-1 (VCAM-1) expression on cultured rheumatoid fibroblast-like synoviocytes. Clin Exp Immunol (1998) 0.89
Relevant change in radiological progression in patients with hip osteoarthritis. II. Determination using an expert opinion approach. Rheumatology (Oxford) (2002) 0.88
Q fever osteoarticular infection: four new cases and a review of the literature. Eur J Clin Microbiol Infect Dis (2007) 0.88
The recanalized umbilical vein in portal hypertension: a myth. AJR Am J Roentgenol (1985) 0.88
The effects of adding interruption to differential reinforcement on targeted and novel self-stimulatory behaviors. J Behav Ther Exp Psychiatry (1984) 0.87
Detection of sequences with Z-DNA forming potential in higher plants. Biochem Biophys Res Commun (1983) 0.87
Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients. Clin Transplant (1999) 0.86
Predictive factors for rapid loss on the mini-mental state examination in Alzheimer's disease. J Nutr Health Aging (2005) 0.86
[Increase of CA 19.9 in dysimmune inflammatory rheumatism. Apropos of 6 cases]. Rev Rhum Ed Fr (1994) 0.86
Two subtypes of BfF by isoelectrofocusing: differential linkage to other HLA markers. Hum Genet (1985) 0.85
Long-term evolution of lymphocytes subsets after induction therapy based on continuous versus discontinuous administration of anti-thymocyte globulins in renal-transplant patients. Transplant Proc (2005) 0.85
Body composition and osteoporosis in elderly women. Gerontology (2000) 0.85
Microsatellites in the HLA region: HLA prediction and strategies for bone marrow donor registries. Transplant Proc (2001) 0.85
Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study. Ann Rheum Dis (2007) 0.85
Oligotyping for HLA-DQA, -DQB, and -DPB in idiopathic nephrotic syndrome. Pediatr Nephrol (1997) 0.84
A role for the endogenous cannabinoid system in the peripheral control of pain initiation. Prog Brain Res (2000) 0.84
[Consensus statement on severe dementia]. Rev Neurol (Paris) (2005) 0.84
Absence of Epstein-Barr virus carrying cells in synovial membranes and subcutaneous nodules of patients with rheumatoid arthritis. Ann Rheum Dis (1993) 0.84
Clinical and densitometric efficacy of the association of interferon alpha and pamidronate in the treatment of osteoporosis in patients with systemic mastocytosis. Clin Rheumatol (2006) 0.84
Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry. Ann Rheum Dis (2010) 0.84
Cases of the day. General. Benign thymic cyst complicated by hemorrhage. Radiographics (1990) 0.84
[The association of B27 positive spondylarthritis with Klinefelter's syndrome]. Presse Med (1990) 0.83